“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database
Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.
New clinical trials added on Feb 03, 2023
A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.
NCT Number : NCT05704634
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
NCT Number : NCT05703295
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced and Incurable Solid Tumors
NCT Number : NCT05705492
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
NCT Number : NCT05705401
Liquid Biopsies in Esophageal Cancer
NCT Number : NCT05704530
The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer
NCT Number : NCT05704231
A Combined Exercise Training Program for Women Living With Breast Cancer
NCT Number : NCT05704855
Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung Cancer
NCT Number : NCT05705466
Integrating Artificial Intelligence Into Lung Cancer Screening.
NCT Number : NCT05704920
Study of Narazaciclib (ON 123300) Plus Letrozole in Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer
NCT Number : NCT05705505
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients (Acclaim-3)
NCT Number : NCT05703971
Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
NCT Number : NCT05704621
NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
NCT Number : NCT05704829
Development of 3DMPUS as a Decision Support Tool for Patients With Liver Tumors Undergoing Therapy
NCT Number : NCT05705219
EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast
NCT Number : NCT05703815
PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
NCT Number : NCT05704166
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
NCT Number : NCT05703269
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
NCT Number : NCT05704647
Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma
NCT Number : NCT05703854
3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer
NCT Number : NCT05704283
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
NCT Number : NCT05704985
Quantitative MRI Assessment of Breast Cancer Therapy Response
NCT Number : NCT05704062
INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701
NCT Number : NCT05703555
FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction
NCT Number : NCT05703997
Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study
NCT Number : NCT05703399
Feasibility and Acceptability of Brief, Telehealth Cognitive Compensatory Training for Pediatric Cancer Patients
NCT Number : NCT05704790
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy
NCT Number : NCT05704842
Develop and Test the Effects of the 'Computer-Assisted OPD COPSCCP on Early Stage Lung Cancer Patients
NCT Number : NCT04506359
Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy
NCT Number : NCT05703581
BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT Number : NCT05703542
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens
NCT Number : NCT05704894
Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)
NCT Number : NCT05704244
Digestive Biobank for Exploring Microbiota-host Interactions
NCT Number : NCT05704413
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
NCT Number : NCT05704933
Assessment of Clonal Hematopoiesis and Its Relationship to Cardiovascular Disease in Hodgkin Lymphoma Survivors
NCT Number : NCT05705531
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
NCT Number : NCT05703516
CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)
NCT Number : NCT05704192
Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)
NCT Number : NCT05703750
Effect of Exercise on Disease Activity in Patients With Ankylosing Spondylitis by SIRI and SII
NCT Number : NCT05703932
The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B
NCT Number : NCT05705141
Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care
NCT Number : NCT05705167
A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
NCT Number : NCT05704049
Exercise Incentives for YMCA Based Exercise
NCT Number : NCT05704712
Videocapsule Endoscopy in Lynch Syndrome
NCT Number : NCT05704010
Reiki and Qi-gong Therapy to Improve Negative Emotional States of Anxiety, Depression, and Stress in Type-2 Diabetics
NCT Number : NCT05704465
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous RO7121932 in Participants With Multiple Sclerosis
NCT Number : NCT05704361
Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
NCT Number : NCT03345134
Intelligent Moxibustion Robot in the Treatment of Low Back Pain
NCT Number : NCT05704127
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
NCT Number : NCT03398135
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
NCT Number : NCT05269004
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
NCT Number : NCT05706740
Assessing the Time Demands of Cancer
NCT Number : NCT05708703
Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer
NCT Number : NCT05705921
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot Study
NCT Number : NCT05707182
Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials
NCT Number : NCT05706974
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT Number : NCT05708924
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
NCT Number : NCT05708599
Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer
NCT Number : NCT05706779
Short-term Outcomes of Laparoscopic Versus Open Gastrectomy With Lymph Node Dissection for Early Gastric Cancer :a Randomized Controlled Study
NCT Number : NCT05707338
Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors
NCT Number : NCT05705687
A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults With Cancer
NCT Number : NCT05706610
Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
NCT Number : NCT05705700
Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer
NCT Number : NCT05707468
A Case Crossover Study of Intermittent Fasting in CLL/SLL
NCT Number : NCT05708326
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors
NCT Number : NCT05708950
Pilot Study to Evaluate Utility of EnteroTracker® as a Minimally Invasive Sampling Method to Screen for Barrett's Esophagus and Esophageal Cancer
NCT Number : NCT05706025
A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population
NCT Number : NCT05708235
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
NCT Number : NCT05706129
A Phase I Clinical Trial Using Genetically Engineered Autologous T Cells to Express Chimeric Antigen Receptor (CAR) for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies
NCT Number : NCT05705570
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NCT Number : NCT05706766
Smoking, Stress, HIV and Mobile Technology
NCT Number : NCT05709002
Retrospective Review of Esophageal Cancer at MSKCC
NCT Number : NCT05706558
Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung Cancer (NSCLC)
NCT Number : NCT05706883
Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies
NCT Number : NCT05707325
Diet and Cognitive Training in Hematologic Cancer Survivors
NCT Number : NCT05708716
Staging Endometrial caNcer Based on molEcular ClAssification
NCT Number : NCT05707312
PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
NCT Number : NCT05707078
NIR Fluorescent Molecular Probe for the Identification of Breast Tissue
NCT Number : NCT05708144
CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission
NCT Number : NCT05707273
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors(MEETCD8-001)
NCT Number : NCT05707676
The Effect of Methods of Self-regulation of Mental State on Pain Perception in the Postoperative Period in Colon Cancer Patients
NCT Number : NCT05708872
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer
NCT Number : NCT05712174
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
NCT Number : NCT05712473
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
NCT Number : NCT05710666
Radiomics-based Malnutrition for Cervical Cancer.
NCT Number : NCT05709769
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
NCT Number : NCT05710328
Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer
NCT Number : NCT05710406
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
NCT Number : NCT05710380
A Prospective, Single-arm, Multicenter Clinical Trial of Safety and Effectiveness of EUS-LA for Liver Cancer
NCT Number : NCT05709886
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
NCT Number : NCT05710848
A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)
NCT Number : NCT05709158
Cost-utility of Focal HIFU vs Prostatectomy
NCT Number : NCT05710861
Rare Embryonal Tumors of the Central Nervous System: International Registry
NCT Number : NCT05711992
Comparison of Ultrasound-guided Erector Spinae Plane Block and Transmuscular Quadratus Lumborum Block
NCT Number : NCT05709899
PSMA-PET/CT Registry
NCT Number : NCT05709535
Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer
NCT Number : NCT05709574
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
NCT Number : NCT05710679
The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer
NCT Number : NCT05710809
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
NCT Number : NCT05711615
Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant
NCT Number : NCT05709912
Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC
NCT Number : NCT05709782
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
NCT Number : NCT05712356
Dose De-escalation in Prostate Radiotherapy Using the MRL
NCT Number : NCT05709496
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
NCT Number : NCT05711667
A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
NCT Number : NCT03469011
Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients
NCT Number : NCT05709522
The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients
NCT Number : NCT05710159
IMM60 and Pembrolizumab in Melanoma and NSCLC
NCT Number : NCT05709821
Busulfan Sample Collection Study
NCT Number : NCT05711732
A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma
NCT Number : NCT05711628
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
NCT Number : NCT02226276
Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage
NCT Number : NCT05707585
Xian-Lian-Jie-Du Optimization Decoction as an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer
NCT Number : NCT05709249
Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery
NCT Number : NCT05711030
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
NCT Number : NCT05707910
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy
NCT Number : NCT05707286
A Prospective Study of Surgical Treatment Strategies for Chordoma
NCT Number : NCT05707767
A Study of HB0030 Injection in Patients With Advanced Solid Tumors
NCT Number : NCT05706207
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors
NCT Number : NCT05712668
A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma
NCT Number : NCT05705583
The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy
NCT Number : NCT05709197
Follow-up of Cell Changes in the Cervix
NCT Number : NCT05709730
Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia
NCT Number : NCT05707702
A Phase 2 Study of the Ketogenic Diet vs Standard Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
NCT Number : NCT05708352
Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
NCT Number : NCT05707819
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
NCT Number : NCT05712694
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
NCT Number : NCT05705635
The Food-effect on Alectinib Pharmacokinetics
NCT Number : NCT05710133
A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia
NCT Number : NCT05712278
Nitrate INFORMER Water Study
NCT Number : NCT05710341
Bicyclol in the Treatment of Antineoplastic Drug-induced Liver Injury.
NCT Number : NCT05711459
Potential Drug Interaction Between ALXN2040 and Rosuvastatin
NCT Number : NCT05708573
Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC
NCT Number : NCT05711823
Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children
NCT Number : NCT05708391
PROs Following Low-dose Irradiation for Osteoarthritis
NCT Number : NCT05705947
Evaluation of Role of Intraoperative Ultrasound in Gross Total Resection of Gliomas
NCT Number : NCT05707728
Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
NCT Number : NCT05707156
A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma
NCT Number : NCT05712083
Biomarker Study in Patients With Trigeminal Neuralgia
NCT Number : NCT05685797
Written Recommendation to Improve Adherence in Poor Bowel Preparation
NCT Number : NCT05709145
Long-term Benefit of MPA in Liver Transplantation
NCT Number : NCT05707520
Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NCT Number : NCT05705791
AI Assisted the Diagnosis of Pancreatic Solid Lesions
NCT Number : NCT05706415
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
NCT Number : NCT04229979
The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study
NCT Number : NCT05712603
Impact of SE of the Proximal Colon on the MAR
NCT Number : NCT05712304
Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions
NCT Number : NCT05710510
A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)
NCT Number : NCT05709093
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
NCT Number : NCT05711719
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
NCT Number : NCT02639299
Lyophilized Fecal Microbiome Transfer Versus Vancomycin Monotherapy for Primary Clostridioides Difficile Infection in Adults (DONATE)
NCT Number : NCT05709184
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT Number : NCT05705973
A Randomized Trial of a Sphenopalatine Ganglion Block With Bupivacaine for Acute Headache
NCT Number : NCT05707754
Gut- and Vaginal Microbiome Composition in Association With PCOS
NCT Number : NCT05706922
Phase II/III Immunogenicity and Safety Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.
NCT Number : NCT05710783
Enter a few details below to get started and we'll help you match up with active clinical trials
8424 Trials found
Cancer Details
Eligibility Criteria
Location
OncoPower Clinical Trial Features
Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you
We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria
Our team will connect you with financial resources available to clinical trial participants
OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial
Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.
There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).
Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.
You are able to leave a clinical trial at any time, for any reason.
Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.
Joan-Smith
Virginia, United States
ChuckHastings
Florida, United States
DebraPearl
Pennsylvania, United States
Jennweeks
Iowa , United States
PatrickDW
Western Cape, South Africa
Jamie-Alexander
Floroda United States
CJ
Liz
Florida, United States
NYCynthia
New York, United States
Ferdi
California, United States
Begin offering a comprehensive digital experience for your patients.
Enter your E-mail address to receive your results